NCT07082166

Brief Summary

Massage therapy, one of the complementary and alternative treatments, is commonly used for fibromyalgia syndrome (FMS). It may help improve pain, anxiety, depression, and sleep disorders through the complex interaction of physical and mental mechanisms. Although studies have investigated massage and extracorporeal shock wave therapy (ESWT) separately, there is currently no study directly comparing these two treatment methods. In this study, we plan to use massage therapy to reduce pain, stiffness, fatigue, and sleep difficulties in individuals with FMS. The aim is to evaluate the effects of both connective tissue massage and ESWT on fibromyalgia symptoms, with a focus on pain, fatigue, sleep disturbances, health status, and quality of life. We also aim to compare the effectiveness of these two non-pharmacological interventions in enhancing general well-being and encouraging participation in daily life. Additionally, we hope this research will contribute to clinical practice by evaluating the potential benefits of connective tissue massage, a safe and cost-effective method.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
2mo left

Started Oct 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Oct 2025Jun 2026

First Submitted

Initial submission to the registry

July 13, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 24, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

October 20, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 12, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 12, 2026

Expected
Last Updated

August 19, 2025

Status Verified

August 1, 2025

Enrollment Period

6 months

First QC Date

July 13, 2025

Last Update Submit

August 17, 2025

Conditions

Keywords

FIBROMYALGIA SYNDROMEConnective Tissue MassageExtracorporeal Shock Wave TherapyPain

Outcome Measures

Primary Outcomes (1)

  • 3.1. Pain (Mcgill)

    Higher scores indicate more severe pain. Description: Consists of 15 pain descriptors (11 sensory, 4 affective), each rated on a scale from 0 (none) to 3 (severe), plus a Visual Analog Scale (VAS) and Present Pain Intensity (PPI)

    6 WEEK

Secondary Outcomes (1)

  • Fibromyalgia Impact Questionnaire

    6 week

Study Arms (1)

CTM GROUP

ESWT GROUP

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients residing in Istanbul who applied to our center, both employed and unemployed, were included

You may qualify if:

  • Clinical diagnosis of fibromyalgia syndrome
  • Aged between 18 and 60 years
  • Female gender
  • Symptoms present for at least 6 months
  • Willing to participate in the study
  • Literate

You may not qualify if:

  • History of rheumatologic, neurologic, psychiatric, or systemic disease
  • Pregnancy or lactation
  • Prior treatment with massage or ESWT
  • History of acute infection, trauma, or surgery
  • History of cancer
  • Use of painkillers or antidepressants
  • Any medical condition that prevents participation in physical activity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Gerontechnology Research Center

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

FibromyalgiaPain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

İlknur Mazı Mazı, PhD Student

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 13, 2025

First Posted

July 24, 2025

Study Start

October 20, 2025

Primary Completion

April 12, 2026

Study Completion (Estimated)

June 12, 2026

Last Updated

August 19, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations